ZANTAC MDL 2924-Recent Rulings and Overall Status

Including comments by Brent Wisner, Baum Hedlund. MASS TORT NEWS January 18, 2021 Washington, DC In Re: Zantac (Ranitidine) Products Liability Litigation MDL 2924 court website JPML Initial Zantac Transfer Order, Feb. 6, 2020 By Mark A. York, Editor ( United States consumers are learning more and more that healthcare manufacturing oversight has failed to monitor […]

Zantac Litigation Overview

Article Provided by Brenden Leydon Attorney at Wocl Leydon LLC The litigation over the harmful effects of Zantac (generic name is Ranitidine) is just getting underway, and it looks like it will lead to a significant number of cases. What is Zantac/Ranitidine? Ranitidine is an antacid which belongs to a class of drugs known as histamine-2 […]

FDA Issues Recall Statement On All Zantac (Ranitidine) Products

FDA NEWS RELEASE FDA Requests Removal of All Ranitidine Products (Zantac) from the Market FDA Advises Consumers, Patients and Health Care Professionals After New FDA Studies Show Risk  The U.S. Food and Drug Administration today announced it is requesting manufacturers withdraw all prescription and over-the-counter (OTC) ranitidine drugs from the market immediately. This is the […]